J&J Halts Late-Stage Trial For Bladder Cancer Prospect

October 9, 2024

Concerns Grow Over Safety of BioGen’s Aduhelm after Death of More Patient Who Got the Drug

February 23, 2022

GSK’s Jemperli Meets Survival Goal in Endometrial Cancer Trial

October 31, 2023

Must Read

FDA Requests Withdrawal of Intercept’s Ocaliva from U.S. Market

September 11, 2025

FDA Approves Inlexzo, Johnson & Johnson’s Breakthrough Bladder Cancer Therapy

September 11, 2025

Sanofi’s Amlitelimab Meets Trial Targets but Falls Short of Analyst Expectations

September 11, 2025

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

Scientists Identify New Target to Prevent Cancer from Spreading to Bones

Sanofi’s Amlitelimab Meets Trial Targets but Falls Short of Analyst Expectations

BioNTech’s HER2 ADC Scores Win In Phase 3 Breast Cancer Trial

Eli Lilly’s Jaypirca Demonstrates Strong Results in Phase 3 CLL Trial

BioNTech and Bristol Myers Squibb Present Global Phase 2 Data for Pumitamig in Small Cell Lung Cancer

Vertex and Enlaza Form $2 Billion Drug Discovery Alliance Focused on Autoimmune and Blood Disorders

BeOne Announces $950M Royalty Deal For Amgen’s Imdelltra

AbbVie Acquires Gilgamesh’s Lead Psychedelic Drug Candidate for Up to $1.2 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Reg impact assessment next in GenAI’s sights, experts claim

The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

Improving life science R&D outcomes with AI

The medical device sector’s surging regulatory burden: how are suppliers coping?

Commercial

Vertex and Enlaza Form $2 Billion Drug Discovery Alliance Focused on Autoimmune and Blood Disorders

BeOne Announces $950M Royalty Deal For Amgen’s Imdelltra

AbbVie Acquires Gilgamesh’s Lead Psychedelic Drug Candidate for Up to $1.2 Billion

Merck KGaA and Skyhawk Therapeutics Sign RNA Drug Discovery Pact Worth Up to $2 Billion

Gilead to Acquire Interius BioTherapeutics for $350 Million to Advance In Vivo CAR-T Therapies

Bayer selects Kumquat for KRAS partnership, offering $1.3 billion if the...

Editor Picks

J&J Halts Late-Stage Trial For Bladder Cancer Prospect

Concerns Grow Over Safety of BioGen’s Aduhelm after Death of More Patient Who Got the Drug

GSK’s Jemperli Meets Survival Goal in Endometrial Cancer Trial

Must Read

FDA Requests Withdrawal of Intercept’s Ocaliva from U.S. Market

FDA Approves Inlexzo, Johnson & Johnson’s Breakthrough Bladder Cancer Therapy

Sanofi’s Amlitelimab Meets Trial Targets but Falls Short of Analyst Expectations

Hot Topics

About Us

Follow Us